查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1490273

個人化精神病學市場，按產品類型、治療領域、最終用戶、技術、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Personalized Psychiatry Market, By Product Type, By Therapeutic Areas, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年個人化精神醫學市場規模為42.0943億美元，2024年至2032年複合年成長率為11.98%。

個人化精神醫學市場-市場動態

精神健康疾病盛行率上升

精神健康疾病發生率的不斷上升極大地推動了個人化精神病學市場的發展。個人化精神病學根據每位患者的個人特徵制定治療計劃，作為對複雜多變的心理健康狀況的回應，正在受到越來越多的關注。越來越多的人被診斷出患有憂鬱症、焦慮症、躁鬱症和精神分裂症等精神健康問題，這是一個主要促進因素。世界衛生組織 (WHO) 報告稱，憂鬱症是全球殘疾的主要原因，影響超過 2.64 億人。人們對心理健康問題的日益認知以及對尋求幫助的污名化正在導致診斷率的提高。數位健康平台和行動健康應用程式的興起透過提供持續監控和即時資料收集來促進個人化護理。

個人化精神醫學市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 11.98% 左右的複合年成長率成長

根據產品類型細分，Genomics 預計將在 2023 年顯示最大的市場佔有率

根據治療領域細分，憂鬱和焦慮是2023年的主導類型

根據最終用戶細分，醫療保健提供者是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

個人化精神醫學市場細分分析：

全球個人化精神病學市場根據產品類型、治療領域、最終用戶、技術和地區進行細分。

根據產品類型，市場分為三類：基因組學、數位治療和軟體。由於數位設備在醫療保健領域的使用不斷增加，基因組學類別將在 2023 年佔據最大的市場佔有率，而數位治療領域預計在未來幾年將以最快的速度發展。由於基因組技術的發展，現在可以識別與精神疾病相關的遺傳差異，這為客製化治療計劃打開了大門。

根據治療領域，市場分為五類：憂鬱症、焦慮症、躁鬱症、成癮症和其他。到2023年，憂鬱症和焦慮症的市場預計將達到相當大的規模，並且在接下來的幾年裡，預計成長速度會更快。對各種疾病之間的變異性的不斷加深的了解，以及不同人的不同根本原因和治療結果。這種理解增加了對個體化診斷和治療方法的需求。

個人化精神病學市場 - 地理洞察

北美心理健康問題日益普遍，推動了對個人化精神干預措施的需求。此外，該地區擁有出色的研究和醫療基礎設施，支援個人化醫療策略的創建和採用。此外，政府對醫療保健創新以及法規和措施的大力投資鼓勵了北美個人化精神病學市場的擴張。預計亞太地區個人化精神病學市場將以最快的速度成長。這一成長的推動因素包括擴大醫療技術投資、提高對心理健康問題的認知以及發展醫療基礎設施。

個人化精神醫學市場-競爭格局：

主要製藥公司擴大投資於個人化精神病學。他們正在根據遺傳和生物標記資訊開發定製藥物。強生（Johnson & Johnson）、輝瑞（Pfizer）和羅氏（Roche）等公司在這一領域表現突出。生物技術公司處於開發創新診斷工具和療法的前沿。他們通常專注於利基領域並利用尖端技術。例子包括 Myriad Genetics、Genomind 和 Assurex Health。製藥公司、生技公司、學術機構和技術供應商之間的合作趨勢日益明顯。這些合作關係對於推進研究並將新的個人化療法推向市場至關重要。例如，2024年5月，最重要的精神病治療和調查平台Osmind宣布與美國精神病學協會（APA）建立突破性合作夥伴關係，以推進基於測量的護理（MBC）的實施以及精神病學的精準治療。

最近的發展：

2021 年 8 月，MindMed 宣布與 Florian 合作，推動焦慮症個人化精神病學的發展。 Florian 在 RWE 和結果研究方面擁有豐富的領域經驗，並開發了各種資訊產品來服務醫療保健產業。

2024 年 5 月，UAB 透過與高級實踐提供者合作擴大了心理健康服務的覆蓋範圍。他們在滿足社區對專業、有能力和獨特的富有同情心的心理健康服務的巨大需求方面發揮著關鍵作用。

目錄

第1章：個人化精神病學市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的個人化精神醫學市場片段
    • 按治療領域分類的個人化精神醫學市場片段
    • 最終用戶的個人化精神病學市場片段
    • 按技術分類的個人化精神病學市場片段
    • 按國家/地區分類的個人化精神病學市場摘要
    • 按地區分類的個人化精神醫學市場片段
  • 競爭洞察

第 3 章：個人化精神醫學主要市場趨勢

  • 個性化精神病學市場促進因素
    • 市場促進因素的影響分析
  • 個人化精神醫學市場限制
    • 市場限制影響分析
  • 個人化精神醫學市場機會
  • 個性化精神病學市場未來趨勢

第 4 章：個人化精神醫學產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：個人化精神醫學市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：個人化精神醫學市場格局

  • 個人化精神病學市場佔有率分析，2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：個人化精神醫學市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 基因組學
    • 數位治療
    • 軟體

第 8 章：個人化精神醫學市場 - 按治療領域

  • 概述
    • 按治療領域分類的細分市場佔有率分析
    • 憂鬱和焦慮
    • 雙極性情感障礙
    • 癮
    • 其他

第 9 章：個人化精神醫學市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 心理健康專家
    • 患者
    • 醫療保健機構

第 10 章：個人化精神醫學市場 - 按技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 定序
    • 聚合酶鍊式反應
    • 微陣列
    • 免疫分析
    • 其他

第 11 章：個人化精神醫學市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美個性化精神病學主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模與預測（按治療領域）
    • 北美市場規模和預測（按最終用戶）
    • 北美市場規模和預測（按技術）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲個性化精神病學主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按治療領域）
    • 歐洲市場規模和預測（按最終用戶）
    • 歐洲市場規模與預測（按技術）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區個人化精神病學主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 按治療領域分類的亞太市場規模和預測
    • 亞太地區市場規模和預測（按最終用戶）
    • 亞太地區市場規模與預測（按技術）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲個性化精神病學主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按治療領域）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 拉丁美洲市場規模與預測（按技術）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲個人化精神病學主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按治療領域）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 中東和非洲市場規模及預測（按技術）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 個人化精神病學產業

  • 競爭儀表板
  • 公司簡介
    • GreyBird Ventures
    • Sunovion Pharmaceuticals Inc.
    • HMNC Holding GmbH
    • Arcara Personalized Psychiatry
    • Starling Minds
    • Karuna Therapeutics
    • CBT Plus
    • AltheaDx, Inc.
    • WayForward
    • BrightQuest
    • Peak Mental Wellness
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2847

REPORT HIGHLIGHT

Personalized Psychiatry Market size was valued at USD 4,209.43 million in 2023, expanding at a CAGR of 11.98% from 2024 to 2032.

The growing incidence of conditions like depression, anxiety, bipolar disorder, and schizophrenia necessitates more effective and personalized treatment methods. Increasing understanding of the genetic basis of psychiatric disorders is enabling more personalized treatment approaches. The development and implementation of personalized treatment plans can be expensive, limiting accessibility for some patients. International efforts to address the global mental health crisis can support the development and dissemination of personalized psychiatry approaches.

Personalized Psychiatry Market- Market Dynamics

Rising Prevalence of Mental Health Disorders

The growing incidence of mental health disorders is significantly propelling the personalized psychiatry market. Personalized psychiatry, which tailors treatment plans to the individual characteristics of each patient, is gaining traction as a response to the complex and varied nature of mental health conditions. The rising number of individuals diagnosed with mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia is a primary driver. The World Health Organization (WHO) reports that depression is a leading cause of disability worldwide, affecting over 264 million people. The growing recognition of mental health issues and the destigmatization of seeking help are contributing to higher diagnosis rates. The rise of digital health platforms and mobile health applications is facilitating personalized care by providing continuous monitoring and real-time data collection.

Personalized Psychiatry Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.98% over the forecast period (2024-2032)

Based on product type segmentation, Genomics was predicted to show maximum market share in the year 2023

Based on therapeutic areas segmentation, Depression and Anxiety was the leading type in 2023

Based on end users segmentation, Healthcare Providers was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Personalized Psychiatry Market- Segmentation Analysis:

The Global Personalized Psychiatry Market is segmented based on Product Type, therapeutic areas, End-user, Technology, and Region.

The market is divided into three categories based on product type: Genomics, Digital Therapeutics, and Software. Due to the rise in the use of digital devices in the healthcare sector, the genomics category holds the largest market share in 2023, while the digital therapeutics segment is predicted to develop at the quickest rate in the upcoming years. Thanks to developments in genomic technologies, it is now possible to identify genetic differences linked to psychiatric diseases, which opens the door to customized treatment plans.

The market is divided into five categories based on therapeutic areas: Depression, Anxiety, Bipolar Disorders, Addiction, and Others. In 2023, the market for depression and anxiety is expected to reach a sizeable amount, and in the ensuing years, it is expected to grow even faster. the expanding understanding of the variability among various illnesses, with different underlying causes and treatment outcomes for different people. This understanding has increased the need for individualized methods of diagnosis and therapy.

Personalized Psychiatry Market- Geographical Insights

The need for individualized psychiatric interventions is being driven by the increasing prevalence of mental health issues in North America. Furthermore, the area has excellent research and healthcare infrastructure, which supports the creation and uptake of personalized medicine strategies. Furthermore, strong investments in healthcare innovation and regulations and initiatives from the government encourage the expansion of the personalized psychiatry market in North America. The personalized psychiatry market is anticipated to grow at the quickest rate in the Asia-Pacific area. This rise is driven by elements including expanding investments in healthcare technology, raising awareness of mental health issues, and developing healthcare infrastructure.

Personalized Psychiatry Market- Competitive Landscape:

Major pharmaceutical companies are increasingly investing in personalized psychiatry. They are developing tailored medications based on genetic and biomarker information. Companies like Johnson & Johnson, Pfizer, and Roche are prominent in this space. Biotechnology companies are at the forefront of developing innovative diagnostic tools and therapies. They often focus on niche areas and leverage cutting-edge technologies. Examples include Myriad Genetics, Genomind, and Assurex Health. There is a growing trend of collaborations between pharmaceutical companies, biotech firms, academic institutions, and technology providers. These partnerships are essential for advancing research and bringing new personalized therapies to market. For instance, in May 2024, Osmind, the foremost psychiatric handling and investigate platform, publicized a ground-breaking partnership with the American Psychiatric Association (APA) to advance the implementation of measurement-based care (MBC) as well as precision dealing in psychiatry.

Recent Developments:

In August 2021, MindMed announced a collaboration with Florian to advance the development of personalized psychiatry for anxiety disorders. Florian has deep domain experience in RWE and outcomes studies and has developed a variety of information products to serve the healthcare industry.

In May 2024, UAB expanded access to mental health services through advanced practice provider collaborations. They are playing a critical role in meeting the community's overwhelming need for professional, competent, and uniquely compassionate mental health services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED PSYCHIATRY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GreyBird Ventures

Sunovion Pharmaceuticals Inc.

HMNC Holding GmbH

Arcara Personalized Psychiatry

Starling Minds

Karuna Therapeutics

CBT Plus

AltheaDx, Inc.

WayForward

BrightQuest

Peak Mental Wellness

Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Genomics
  • Digital Therapeutics
  • Software

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY THERAPEUTIC AREAS - MARKET ANALYSIS, 2019 - 2032

  • Depression and Anxiety
  • Bipolar Disorders
  • Addiction
  • Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032

  • Mental Health Professionals
  • Patients
  • Healthcare Providers

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Sequencing
  • Polymerase Chain Reaction
  • Microarray
  • Immunoassay
  • Others

GLOBAL PERSONALIZED PSYCHIATRY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Personalized Psychiatry Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Personalized Psychiatry Market Snippet by Product Type
    • 2.1.2.Personalized Psychiatry Market Snippet by Therapeutic Areas
    • 2.1.3.Personalized Psychiatry Market Snippet by End User
    • 2.1.4.Personalized Psychiatry Market Snippet by Technology
    • 2.1.5.Personalized Psychiatry Market Snippet by Country
    • 2.1.6.Personalized Psychiatry Market Snippet by Region
  • 2.2.Competitive Insights

3.Personalized Psychiatry Key Market Trends

  • 3.1.Personalized Psychiatry Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Personalized Psychiatry Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Personalized Psychiatry Market Opportunities
  • 3.4.Personalized Psychiatry Market Future Trends

4.Personalized Psychiatry Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Personalized Psychiatry Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Personalized Psychiatry Market Landscape

  • 6.1.Personalized Psychiatry Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Personalized Psychiatry Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Genomics
    • 7.1.3.Digital Therapeutics
    • 7.1.4.Software

8.Personalized Psychiatry Market - By Therapeutic Areas

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Therapeutic Areas, 2023 & 2032 (%)
    • 8.1.2.Depression and Anxiety
    • 8.1.3.Bipolar Disorders
    • 8.1.4.Addiction
    • 8.1.5.Others

9.Personalized Psychiatry Market - By End User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2.Mental Health Professionals
    • 9.1.3.Patients
    • 9.1.4.Healthcare Providers

10.Personalized Psychiatry Market - By Technology

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 10.1.2.Sequencing
    • 10.1.3.Polymerase Chain Reaction
    • 10.1.4.Microarray
    • 10.1.5.Immunoassay
    • 10.1.6.Others

11.Personalized Psychiatry Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Personalized Psychiatry Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Personalized Psychiatry Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Personalized Psychiatry Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Personalized Psychiatry Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Personalized Psychiatry Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Personalized Psychiatry Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.GreyBird Ventures
    • 12.2.2.Sunovion Pharmaceuticals Inc.
    • 12.2.3.HMNC Holding GmbH
    • 12.2.4.Arcara Personalized Psychiatry
    • 12.2.5.Starling Minds
    • 12.2.6.Karuna Therapeutics
    • 12.2.7.CBT Plus
    • 12.2.8.AltheaDx, Inc.
    • 12.2.9.WayForward
    • 12.2.10.BrightQuest
    • 12.2.11.Peak Mental Wellness
    • 12.2.12.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Personalized Psychiatry Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Personalized Psychiatry Market, by Product Type 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: Therapeutic Areas Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Areas
  • TABLE Global Personalized Psychiatry Market, by Therapeutic Areas 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Personalized Psychiatry Market, by End User 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Personalized Psychiatry Market, by Technology 2019-2032 (USD Million)
  • TABLE Personalized Psychiatry Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Personalized Psychiatry Market, by Region 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE North America Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Therapeutic Areas, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Personalized Psychiatry Market, by Technology, 2019-2032 (USD Million)